These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 7707443)

  • 21. Lactate dehydrogenase-elevating virus entry into the central nervous system and replication in anterior horn neurons.
    Anderson GW; Palmer GA; Rowland RR; Even C; Plagemann PG
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():581-92. PubMed ID: 7897349
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of immune complexes during infection of mice with lactate dehydrogenase-elevating virus: studies with interferon-gamma gene knockout and tolerant mice.
    Cafruny WA; Bradley SE; Rowland RR
    Viral Immunol; 1999; 12(2):163-73. PubMed ID: 10413362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of lactate dehydrogenase-elevating virus ORF6 protein expressed by recombinant baculoviruses.
    Takahashi-Omoe H; Omoe K; Matsushita S; Inada T
    Comp Immunol Microbiol Infect Dis; 2004 Nov; 27(6):423-31. PubMed ID: 15325515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
    Morimoto M; Ohji T; Iwata H; Hayashi T
    Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lactic dehydrogenase virus infection enhances parasite egg production and inhibits eosinophil and mast cell responses in mice infected with the nematode Nippostrongylus brasiliensis.
    Morimoto M; Yamada M; Arizono N; Hayashi T
    Immunology; 1998 Apr; 93(4):540-5. PubMed ID: 9659227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
    Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
    J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lactate dehydrogenase-elevating virus infection at the sensitization and challenge phases reduces the development of delayed eosinophilic allergic rhinitis in BALB/c mice.
    Sasaki Y; Hayashi T; Hasegawa K
    Scand J Immunol; 2007 Dec; 66(6):628-35. PubMed ID: 17949409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clearance of LDH-5 from the circulation of inbred mice correlates with binding to macrophages.
    Hayashi T; Notkins AL
    Int J Exp Pathol; 1994 Jun; 75(3):165-8. PubMed ID: 8086313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of development of anti-nuclear antibody and glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: possible involvement of superoxide anion as a progressive effector.
    Hayashi T; Noguchi Y; Kameyama Y
    Int J Exp Pathol; 1993 Dec; 74(6):553-60. PubMed ID: 8292553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suppression of development of glomerulonephritis in NZB x NZWF1 mice by persistent infection with lactic dehydrogenase virus: relations between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli.
    Kameyama Y; Hayashi T
    Int J Exp Pathol; 1994 Aug; 75(4):295-304. PubMed ID: 7947231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of infection by lactic dehydrogenase virus on expression of intercellular adhesion molecule-1 on vascular endothelial cells of pancreatic islets in streptozotocin-induced insulitis of CD-1 mice.
    Hayashi T; Hashimoto S; Kawashima A
    Int J Exp Pathol; 1994 Jun; 75(3):211-7. PubMed ID: 7916200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The neutralization epitope of lactate dehydrogenase-elevating virus is located on the short ectodomain of the primary envelope glycoprotein.
    Li K; Chen Z; Plagemann P
    Virology; 1998 Mar; 242(2):239-45. PubMed ID: 9514969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The LDH virus: an interfering biological contaminant.
    Riley V; Spackman DH; Santisteban GA; Dalldorf G; Hellstrom I; Hellstrom KE; Lance EM; Rowson KE; Mahy BW; Alexander P; Stock CC; Sjogren HO; Hollander VP; Horzinek MC
    Science; 1978 Apr; 200(4338):124-6. PubMed ID: 263259
    [No Abstract]   [Full Text] [Related]  

  • 35. ORF 3 of lactate dehydrogenase-elevating virus encodes a soluble, nonstructural, highly glycosylated, and antigenic protein.
    Faaberg KS; Plagemann PG
    Virology; 1997 Jan; 227(1):245-51. PubMed ID: 9007081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exacerbation of murine malaria by concurrent infection with lactic dehydrogenase-elevating virus.
    Henderson DC; Tosta CE; Wedderburn N
    Clin Exp Immunol; 1978 Aug; 33(2):357-9. PubMed ID: 719954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of three bleeding techniques on lactic dehydrogenase levels in mice: implications for lactic dehydrogenase virus bioassay.
    Dillberger JE; Monroy P; Altman NH
    Lab Anim Sci; 1987 Jun; 37(3):356-9. PubMed ID: 3613520
    [No Abstract]   [Full Text] [Related]  

  • 38. Involvement of Fcα/μ Receptor in IgM Anti-Platelet, but Not Anti-Red Blood Cell Autoantibody Pathogenicity in Mice.
    Legrain S; Su D; Breukel C; Detalle L; Claassens JW; van der Kaa J; Izui S; Verbeek JS; Coutelier JP
    J Immunol; 2015 Nov; 195(9):4171-5. PubMed ID: 26385523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cancer xenografts in humans: opportunity for modeling cancer disease in humans and it's treatment].
    Poupon MF
    Ann Pathol; 2006 Nov; 26 Spec No 1():1S51-3. PubMed ID: 17149178
    [No Abstract]   [Full Text] [Related]  

  • 40. From bench to cageside: Risk assessment for rodent pathogen contamination of cells and biologics.
    Peterson NC
    ILAR J; 2008; 49(3):310-5. PubMed ID: 18506064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.